CIESP

Clinical experience with thymoglobulin and antithymocyte globulin-Fresenius as induction therapy in renal transplant patients: a retrospective study

F. Cicora,F. Mos,M. Paz and J. Roberti. Clinical experience with thymoglobulin and antithymocyte globulin-Fresenius as induction therapy in renal transplant patients: a retrospective study. Exp Clin Transplant. 2013;11(5):10.6002/ect.2013.0027.

Clinical experience with thymoglobulin and antithymocyte globulin-Fresenius as induction therapy in renal transplant patients: a retrospective study Ver más »

Challenges Faced By Decision Makers From Middle Income Countries In Transferring Pharmacoeconomic Data And Analyses From Other Jurisdictions

M. Drummond,F. Augustovski,Z. Kalo,B. M. Yang,A. Pichon-Riviere,E. Y. Bae and S. Kamal-Bahl. CHALLENGES FACED BY DECISION MAKERS FROM MIDDLE INCOME COUNTRIES IN TRANSFERRING PHARMACOECONOMIC DATA AND ANALYSES FROM OTHER JURISDICTIONS. Value in Health. 2014;17(3):10.1016/j.jval.2014.03.161.

Challenges Faced By Decision Makers From Middle Income Countries In Transferring Pharmacoeconomic Data And Analyses From Other Jurisdictions Ver más »

Cardiovascular Disease Prognostic Models in Latin America and the Caribbean: A Systematic Review

R. M. Carrillo-Larco,C. Altez-Fernandez,N. Pacheco-Barrios,C. Bambs,V. Irazola,J. J. Miranda,G. Danaei and P. Perel. Cardiovascular Disease Prognostic Models in Latin America and the Caribbean: A Systematic Review. Glob Heart. 2019;14(1):10.1016/j.gheart.2019.03.001.

Cardiovascular Disease Prognostic Models in Latin America and the Caribbean: A Systematic Review Ver más »

CALIBRATION OF A COST-EFFECTIVENESS MODEL TO EVALUATE THE INCORPORATION OF A QUADRIVALENT HPV TYPES 6, 11, 16, 18 VACCINE IN ARGENTINA: DISEASE BURDEN COMPONENT

A. Pichon-Riviere,J. Caporale,A. Alcaraz,A. Bardach,K. Klein,L. R. Ares and F. Augustovski. CALIBRATION OF A COST-EFFECTIVENESS MODEL TO EVALUATE THE INCORPORATION OF A QUADRIVALENT HPV TYPES 6, 11, 16, 18 VACCINE IN ARGENTINA: DISEASE BURDEN COMPONENT. Value in Health. 2013;16(7):10.1016/j.jval.2013.08.2126.

CALIBRATION OF A COST-EFFECTIVENESS MODEL TO EVALUATE THE INCORPORATION OF A QUADRIVALENT HPV TYPES 6, 11, 16, 18 VACCINE IN ARGENTINA: DISEASE BURDEN COMPONENT Ver más »

Calcium-fortified foods in public health programs: considerations for implementation

C. Palacios,G. Cormick,G. J. Hofmeyr,M. N. Garcia-Casal,J. P. Pena-Rosas and A. P. Betran. Calcium-fortified foods in public health programs: considerations for implementation. Annals of the New York Academy of Sciences. 2021;1485(1):10.1111/nyas.14495.

Calcium-fortified foods in public health programs: considerations for implementation Ver más »

Calcium concentration of drinking water to improve calcium intake: A simulation study

G. Cormick,I. B. Romero,N. Matamoros,M. Sosa,M. F. GugoleOttaviano,L. Garitta,J. M. Belizán and L. Gibbons. Calcium concentration of drinking water to improve calcium intake: A simulation study. Ann N Y Acad Sci. 2023;1524(1):10.1111/nyas.14986.

Calcium concentration of drinking water to improve calcium intake: A simulation study Ver más »

Budget impact analysis-principles of good practice: report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force

S. D. Sullivan,J. A. Mauskopf,F. Augustovski,J. Jaime Caro,K. M. Lee,M. Minchin,E. Orlewska,P. Penna,J. M. Rodriguez Barrios and W. Y. Shau. Budget impact analysis-principles of good practice: report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force. Value Health. 2014;17(1):10.1016/j.jval.2013.08.2291.

Budget impact analysis-principles of good practice: report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force Ver más »

Budget Impact Analysis of Venetoclax for Management of Acute Myeloid Leukemia from the Perspective of the Social Security and the Private Sector in Argentina

A. Palacios,N. Espinola,J. M. Gonzalez,M. M. Rivas,C. Rojas-Roque,D. Kanevsky,P. Morisset,F. Augustovski,D. A. Pichon-Riviere and A. Bardach. BUDGET IMPACT ANALYSIS OF VENETOCLAX FOR MANAGEMENT OF ACUTE MYELOID LEUKEMIA FROM THE PERSPECTIVE OF THE SOCIAL SECURITY AND THE PRIVATE SECTOR IN ARGENTINA. Value in Health. 2022;25(1):https://doi.org/10.1016/j.jval.2021.11.316.

Budget Impact Analysis of Venetoclax for Management of Acute Myeloid Leukemia from the Perspective of the Social Security and the Private Sector in Argentina Ver más »

Brief Latin American Update: One More ViHRI Annual Issue, and Another Exciting Biennial ISPOR Conference

F. Augustovski,V. Zárate,J. Caro and M. B. Ferraz. Brief Latin American Update: One More ViHRI Annual Issue, and Another Exciting Biennial ISPOR Conference. Value Health Reg Issues. 2015;8:10.1016/j.vhri.2015.10.005.

Brief Latin American Update: One More ViHRI Annual Issue, and Another Exciting Biennial ISPOR Conference Ver más »